MEC Plus

HRPC: How to Sequence Multiple Therapies
HRPC: How to Sequence Multiple Therapies
Daniel P Petrylak - MD
Immunotherapy for Head and Neck Cancers
Immunotherapy for Head and Neck Cancers
Cesar A Perez, MD
From Bench to Bedside (and Back): Early Clinical Trials
From Bench to Bedside (and Back): Early Clinical Trials
Patricia LoRusso, DO, PhD
EGFR Mutations: What's Next?
EGFR Mutations: What's Next?
Natasha Leighl, MD, FASCO, FRCPS, MMSc
Choosing Optimal Therapy for Relapsed Multiple Myeloma Patient
Choosing Optimal Therapy for Relapsed Multiple Myeloma Patient
Shaji Kumar, MD
Myelodysplasia Syndromes and Secondary AML
Myelodysplasia Syndromes and Secondary AML
Rami Komrokji, MD
Cancer and Thrombosis: What is the Role of Direct Oral Anticoagulants?
Cancer and Thrombosis: What is the Role of Direct Oral Anticoagulants?
Craig S Kitchens, MD, MACP
Chimeric Antigen Receptor (CAR) T-Cell Therapy: Progress and Challenges
Chimeric Antigen Receptor (CAR) T-Cell Therapy: Progress and Challenges
Mohamed A Kharfan-Dabaja, MD, MBA, FACP
Advances in the Treatment of Triple-Negative Metastatic Breast Cancer
Advances in the Treatment of Triple-Negative Metastatic Breast Cancer
Mohammad Jahanzeb, MD, FACP
Immunotherapy in Kidney and Bladder Cancers
Immunotherapy in Kidney and Bladder Cancers
Mike Hurwitz, MD, PhD
Peripheral T-Cell Lymphoma: Novel Agents & New Horizons
Peripheral T-Cell Lymphoma: Novel Agents & New Horizons
Steven M Horwitz, MD
Immunotherapies in Gynecologic Malignancies
Immunotherapies in Gynecologic Malignancies
Thomas J Herzog, MD
Small Cell and Neuroendocrine Carcinoma of the Lung
Small Cell and Neuroendocrine Carcinoma of the Lung
Christine L Hann, MD, PhD
Colon Cancer: Are We Making Progress?
Colon Cancer: Are We Making Progress?
Axel Grothey
Updates in Pancreatic and Biliary Cancers
Updates in Pancreatic and Biliary Cancers
Ignacio Garrido-Laguna, MD, PhD
Updates on Emesis, Neutropenia and Bone Metastases
Updates on Emesis, Neutropenia and Bone Metastases
Lorinda A Coombs, PhD, FNP-BC, AOCNP
ASCO Update on Sarcomas
ASCO Update on Sarcomas
Pasquale Benedetto, MD
ALK Mutant NSCLC
ALK Mutant NSCLC
Lyudmila Bazhenova, MD
Melanoma- Novel Therapies Including Immunotherapy
Melanoma- Novel Therapies Including Immunotherapy
Sanjiv S Agarwala, MD
Immunotherapy in Colorectal Cancer & MSI-High Solid Cancers
Immunotherapy in Colorectal Cancer & MSI-High Solid Cancers
Ahmed Zakari, MD
Neuroendocrine Tumors of the Lung "A Spectrum of Clinical Challenges"
Neuroendocrine Tumors of the Lung "A Spectrum of Clinical Challenges"
Antoinette J Wozniak, MD, FACP, FASCO
Brain Tumors
Brain Tumors
Eric T Wong, MD
Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neodjuvant
Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neodjuvant
Michel Velez, MD
ER/PR and CDK Pathways in the Management of ER+ Metastatic Breast Cancer
ER/PR and CDK Pathways in the Management of ER+ Metastatic Breast Cancer
Vicente Valero, MD, FACP
CAR-T Cells: Learning How to Deal with Complications
CAR-T Cells: Learning How to Deal with Complications
Jessica Unzaga, PharmD, BCPS, BCOP
Health, Wellness and Cancer Prevention
Health, Wellness and Cancer Prevention
Orlando E Silva, MD
Other Driver Mutations: ROS-1, RET, Her-2, MET, Exon 20 Insertions
Other Driver Mutations: ROS-1, RET, Her-2, MET, Exon 20 Insertions
Edgardo S Santos, MD, FACP
EGFR & ALK: Where Are We Now?
EGFR & ALK: Where Are We Now?
Jacob Sands, MD
Integrative Survivorship in Cancer Care
Integrative Survivorship in Cancer Care
Maray Salina, MSN, APRN, FNP-BC